B-Cell Chronic Lymphocytic Leukemia Active Not Recruiting Phase 3 Trials for Lenalidomide (DB00480)

Also known as: B-cell Chronic Lymphocytic Leukemia / Chronic lymphocytic leukemia / Leukemia lymphocytic chronic / CLL / Chronic lymphoid leukaemia / Lymphoid leukaemia, chronic / Lymphoid leukemia, chronic / Chronic lymphatic leukaemia / Chronic lymphoid leukemia / Leukaemia lymphocytic chronic / Chronic lymphatic leukemia / Chronic lymphocytic leukaemia NOS / Leukaemias chronic lymphocytic / Chronic lymphocytic leukaemia / Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoplasmacytic leukemia / B-cell chronic lymphocytic leukaemia

IndicationStatusPhase
DBCOND0030547 (B-Cell Chronic Lymphocytic Leukemia)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00774345A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line TherapyTreatment
NCT00910910Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)Treatment